Dr. Daniel George on the Treatment Landscape for RCCByDaniel George, MDJune 11th 2019Cancer Network spoke with Daniel George, MD, of Duke Health, about the treatment landscape and current trials for renal cell carcinoma.
Can mRCC Patients Be Spared Debulking Nephrectomy?ByDaniel George, MDJune 12th 2018In this video, Dr. Daniel George discusses CARMENA, which asked if cytoreductive surgery is necessary in the age of active systemic therapy for mRCC.